insights_auto
Why is BOT down १०.००%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.००९०
arrow_downward
-१०.००%(-०.००१०) 1D
नोभेम्बर १३, १६:१०:१२ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.४९ करोड
Avg. vol.
१.०१ करोड
Volume
९.४७ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.४९ करोड
Avg. vol.
१.०१ करोड
Volume
९.४७ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
Briefs Finance
·
१८ मिनेट पहिले
Nasdaq Dips as Nvidia Slides, Major Indexes Gain Weekly
Seeking Alpha
·
१ घण्टा पहिले
S&P 500 Snapshot: Stocks Up 2.5% To Log Best Week Since August
TradingKey
·
१ घण्टा पहिले
Is the US Stock Selloff Over? Wall Street Debates AI Bubble as S&P 500, Chip Stocks Diverge for 2027
CNBC
·
११ घण्टा पहिले
Is a bottom in for the Nasdaq-100? Charts to watch
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd